This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Early renal disease is associated with activation of the mevalonate pathway, which, in turn, leads to progression of renal disease and the development and progression of cardiovascular disease (CVD). We postulate that: (1) the mevalonate pathway is activated in early chronic renal insufficiency (CRI); and (2) activation of the mevalonate pathway is associated with increased risk for CVD. To test these hypotheses we will conduct a case-control study of participants with normal renal function, and incipient or overt renal disease.
Showing the most recent 10 out of 568 publications